Angle announces new results for dual analysis of CTC-DNA and ctDNA using Illumina assay and sequencing platform: London Saturday, February 1, 2025, 15:00 Hrs [IST] Angle plc, a wo ...

John West, general manager of Illumina's DNA sequencing business unit and Kevin McKernan, an inventor of the Applied Biosystem's SOLiD System technology, both say their companies are playing with ...

Cancer is a disease of the genome, according to Dr. Elli Papaemmanuil, computational oncologist at MSK. By looking at the ...

NEW RESULTS FOR dual analysis of CTC-DNA and ctDNA using Illumina assay and sequencing platform Findings in lung cancer show ...

The next-generation sequencing market valued at US$ 13.92 billion in 2023, is forecasted to grow at a robust CAGR of 11.0%, ...

Illumina recently launched the MiSeq i100 and MiSeq i100 Plus Systems, two powerful, compact benchtop sequencers that ...

Stock analysts at Leerink Partnrs lifted their Q4 2025 earnings per share (EPS) estimates for shares of Illumina in a research note issued to investors on Tuesday, January 21st. Leerink Partnrs ...

Report on how AI is redefining market landscape - The global genomics market size is estimated to grow by USD 5.21 billion ...

Angle PLC on Wednesday released successful results from its new dual circulating tumour DNA and circulating tumour cell DNA workflow, using Illumina Inc's sequencing technology for the first time. The ...

Rising demand for precision medicine & groundbreaking innovations in RNA sequencing drive growth in oncology, drug discovery, & personalized therapies. Akash Anand SNS Insider Pvt. Ltd 415-230-0044 ...